Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “chimeric”

309 pharma patents match "chimeric" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 309
Index total 30,257
Page 9 / 13

Quick answer

This filtered view shows 309 pharmaceutical patents matching "chimeric" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

309 results for “chimeric” · 30,257 patents in full index Clear search

  1. IL 240179

    Use of a monoclonal, chimeric, human antibody that binds il-5r in the manufacture of a medicament for reducing the numbers of blood basophils in a human subject

    BIOWA INC [US] · Granted Dec 31, 2018 · Expires Dec 26, 2038

    granted
  2. US 10125193

    Chimeric antigen receptors and methods of making

    The Board of Regents of the University of Texas System · Granted Nov 13, 2018 · Expires Nov 8, 2038

    granted
  3. US 10105391

    Chimeric antigen receptor and methods of use thereof

    The Regents of the University of California · Granted Oct 23, 2018 · Expires Oct 18, 2038

    granted
  4. US 10106610

    Antibodies comprising chimeric constant domains

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 23, 2018 · Expires Oct 18, 2038

    granted
  5. US 10072078

    M971 chimeric antigen receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted
  6. US 10022450

    Regulation of specific spinal neurons regulating pain transmission via chimeric toxins

    The Regents of the University of California · Granted Jul 17, 2018 · Expires Jul 12, 2038

    granted
  7. US 10010622

    Factor VIII chimeric and hybrid polypeptides, and methods of use thereof

    BIOVERATIV THERAPEUTICS INC. · Granted Jul 3, 2018 · Expires Jun 28, 2038

    granted
  8. US 10000551

    Chimeric polypeptides, polynucleotides encoding same, cells expressing same and methods of producing same

    Protalix Ltd. · Granted Jun 19, 2018 · Expires Jun 14, 2038

    granted
  9. US 9951118

    Engineering antiviral T cell immunity through stem cells and chimeric antigen receptors

    The Regents of the University of California · Granted Apr 24, 2018 · Expires Apr 19, 2038

    granted
  10. US 9868774

    Anti-CD22 chimeric antigen receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 16, 2018 · Expires Jan 11, 2038

    granted
  11. US 9821012

    Chimeric antigen receptor and methods of use thereof

    The Regents of the University of California · Granted Nov 21, 2017 · Expires Nov 16, 2037

    granted
  12. US 9783579

    Compositions and methods for dengue virus chimeric constructs in vaccines

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted
  13. US 9783787

    Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1, 2, 3, and 4, or antigenic chimeric dengue viruses 1, 2, 3, and 4

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted
  14. US 9765342

    Chimeric antigen receptors targeting B-cell maturation antigen

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted
  15. US 9725496

    Immunoglobulin chimeric monomer-dimer hybrids

    BIOVERATIV THERAPEUTICS INC. · Granted Aug 8, 2017 · Expires Aug 3, 2037

    granted
  16. US 9708386

    Modified chimeric polypeptides with improved pharmacokinetic properties

    REGENERON PHARMACEUTICALS, INC. · Granted Jul 18, 2017 · Expires Jul 13, 2037

    granted
  17. US 9637524

    Proteolysis-resistant capsid of chimeric hepatitis E virus as an oral delivery vector

    The Regents of the University of California · Granted May 2, 2017 · Expires Apr 27, 2037

    granted
  18. US 9636416

    Immunoglobulin chimeric monomer-dimer hybrids

    BIOVERATIV THERAPEUTICS INC. · Granted May 2, 2017 · Expires Apr 27, 2037

    granted
  19. US 9631192

    Auto-recognizing therapeutic RNA/DNA chimeric nanoparticles (NP)

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted
  20. US 9629877

    Human application of engineered chimeric antigen receptor (CAR) T-cells

    The Board of Regents of the University of Texas System · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted
  21. US 9623085

    Chimeric natriuretic peptide compositions and methods of preparation

    Capricor Therapeutics, Inc. · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted
  22. US 9624306

    Anti-epidermal growth factor receptor variant III chimeric antigen receptors and use of same for the treatment of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted
  23. US 9587020

    Chimeric antigen receptor and methods of use thereof

    The Regents of the University of California · Granted Mar 7, 2017 · Expires Mar 2, 2037

    granted
  24. US 9522955

    Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of same for the treatment of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 20, 2016 · Expires Dec 15, 2036

    granted